Feature | May 05, 2015

Jacksonville, Florida facility employs Mevion single-room proton therapy system

Ackerman Cancer Center, Mevion S250, Jacksonville, physician-owned

May 5, 2015 — Ackerman Cancer Center in Jacksonville, Florida, treated its first four proton therapy patients at the end of April, becoming the first private, physician-owned practice to offer this advanced form of radiation therapy. Within the first week of operation with the new system — a Mevion S250 — eight patients began proton therapy, with cancers affecting the parotid (salivary gland), prostate, tongue and base of the skull.

Before the introduction of the Mevion S250, proton therapy systems were the size of a football field and cost hundreds of millions of dollars to build and operate, thus limiting patient access. Mevion’s proton therapy system is installed into a single room with a footprint similar to a conventional radiation therapy unit, allowing it to be integrated with any size cancer facility. In addition, the Mevion system features greatly decreased capital and operating costs and is more environmentally friendly – using as much as 90 percent less energy than traditional systems.

Proton therapy targets cancer cells more precisely than traditional photon radiation treatment and results in less damage to surrounding healthy tissue and organs. Because of these attributes, it is ideal for treating pediatric patients and adult patients with cancers in sensitive locations, such as near the brain, spine, heart and lungs.

“We are a full-service cancer center, offering a complement of treatment options – allowing us to choose the modality that is most appropriate for each patient,” said Scot Ackerman, M.D., radiation oncologist and medical director of Ackerman Cancer Center. “Proton therapy is an important radiation oncology treatment and one that our patients deserve to be able to access as we help them fight their cancers.”

Ackerman Cancer Center’s system is the second clinically operational Mevion S250, with the other located at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, Missouri. One-year clinical results indicate it took less than 11 months to complete treatment of its first 100 patients – the fastest per room ramp-up of any proton therapy system. Additionally, the system demonstrated efficient treatment time identical to X-ray therapy, the ability to treat a diverse and complex array of cancers and operational uptime reaching 97 percent.

For more information: www.mevion.com


Related Content

News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
Subscribe Now